Results 91 to 100 of about 898 (115)

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists. [PDF]

Curr Opin Rheumatol
Ford JA, Gewurz-Singer O.
europepmc   +1 more source

New Anticomplement Drugs in Nephrology: Mechanism and Indication.

Kidney Blood Press Res
Macciò L, Russo E, Costigliolo F, Battaglia Y, Viazzi F, Esposito P.   +5 more
europepmc   +1 more source

Breaking tolerance in the glomerulus: complement as a driver and therapeutic target in IgA nephropathy. [PDF]

Front Med (Lausanne)
Lu CL, Yang CC, Wu CC, Lu KC.
europepmc   +1 more source

WCN24-750 ASSESSMENT OF DRUG INTERACTIONS WITH IPTACOPAN

Kidney International Reports
Robert Schmouder, Kenneth Kulmatycki, Bharti Shah, Amanda Taylor, Prasanna Kumar Nidamarthy   +4 more
doaj   +1 more source

Current and Emerging Therapies for C3 Glomerulopathy and Primary (Idiopathic) Immune Complex Membranoproliferative Glomerulonephritis. [PDF]

Kidney Int Rep
Kavanagh D, Ariceta G, Vivarelli M, Schaefer F, Caravaca-Fontán F, Frémeaux-Bacchi V, Fakhouri F, Licht C, Pickering MC.   +8 more
europepmc   +1 more source

IgA nephropathy management: what does the future hold? [PDF]

Kidney Int Suppl (2011)
Tang SCW, Reich HN.
europepmc   +1 more source

Complement-Mediated Kidney Diseases: Role of Alternative Pathway in Glomerular Inflammation. [PDF]

Kidney Int Rep
Barratt J, Garred P, Lafayette RA, Zhang H, Floege J.   +4 more
europepmc   +1 more source

WCN24-550 SINGLE DOSE OF IPTACOPAN TREATMENT RAPIDLY DESCREASES PLASMA COMPLEMENT Bb LEVELS

Kidney International Reports
Robert Schmouder, Guido Junge, Julie Milojevic, Prasanna Kumar Nidamarthy, Kenneth Kulmatycki   +4 more
doaj   +1 more source

WCN24-748 ASSESSMENT OF THE EFFECT OF HEPATIC IMPAIRMENT ON IPTACOPAN PHARMACOKINETICS

Kidney International Reports
Robert Schmouder, Kenneth Kulmatycki, Elise Burmeister Getz, Wendy Weiss, Bharti Shah   +4 more
doaj   +1 more source

Evolving therapeutic landscape of immunoglobulin A nephropathy: targeted immune pathways and novel therapies. [PDF]

Kidney Res Clin Pract
Kim Y.
europepmc   +1 more source